Loading organizations...
Loading organizations...
Biopharmaceutical company developing biosimilars and contract manufacturing
Eden Biologics has raised $80.6M across 2 funding rounds.
Eden Biologics has raised $80.6M in total across 2 funding rounds.
Eden Biologics has raised $80.6M in total across 2 funding rounds.
Eden Biologics's investors include Liwick Investment Management, Milestone Capital, Sungent BioVenture, Allen Chao, Biomark Capital, CDIB Capital Group, Fubon Ventures, Hotung Venture Group, Kleiner Perkins, President International Development Corporation, Taian Venture Capital, Taishin Financial Holdings.
Eden Biologics has raised $80.6M across 2 funding rounds. Most recently, it raised $45.6M Series C in May 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 12, 2015 | $45.6M Series C | Liwick Investment Management, Milestone Capital, Sungent BioVenture | |
| Jun 20, 2014 | $35.0M Series B | Milestone Capital | Allen Chao, Biomark Capital, CDIB Capital Group, Fubon Ventures, Hotung Venture Group, Kleiner Perkins, President International Development Corporation, Taian Venture Capital, Taishin Financial Holdings |